Delivery Order SPE2DB22D3501-SPE2DB24FWF30
Award Date
7/9/24
Potential Completion Date
7/30/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division provides for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $51,841.24 firm fixed price delivery order contract has a completion date of June 6, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC,...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, to the Department of Defense (DoD) and its Medical Supply Chain agency. The ceiling value of the firm-fixed-price delivery order is $51,841.24, with a period of performance through June 20, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with the Defense...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $38,880.93 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the provision of VYNDAMAX 61 MG CAPSULE UD 30S, a prescription pharmaceutical product, with a period of performance through June 25, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order worth $49,381.36 to provide VYNDAMAX 61 MG CAPSULE UD 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with the DLA with a potential value of $999,999,999.00 and a performance period through December 31,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty medication. The fixed-price delivery order, valued at $12,960.30, has an ultimate completion date of August 5, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S. The $25,920.62 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, with a completion date of September 26, 2024. This contract is not set aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $12,960.30 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VYNDAMAX 61 MG CAPSULE UD 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S pharmaceutical products. The contract, valued at $25,920.62, was awarded by the Defense Logistics Agency (DLA) as a firm-fixed-price delivery order and has a completion date of June 20, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract has a ceiling value of $25,920.62 and a completion date of July 15, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to various federal agencies, including...
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a completion date of June 5, 2024. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...